Transformation to plasmablastic lymphoma in CLL upon ibrutinib treatment

Chronic lymphatic leukaemia (CLL) is the most common leukaemia in the Western world. Ibrutinib, a tyrosine kinase inhibitor, is the treatment of choice on relapse or p53-dysfunction. Richter’s transformation to diffuse large B cell lymphoma is most often seen. However, transformation to other aggres...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ Case Rep
Hauptverfasser: Marvyin, Kristo, Tjønnfjord, Eirik Brekka, Breland, Unni Mathilde, Tjønnfjord, Geir Erland
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2020
Schlagworte:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7526319/
https://ncbi.nlm.nih.gov/pubmed/32994268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-235816
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge